Suzuken Co., Ltd.
Stock Price Chart
2026/08/07 UpdatedPrice Trend
2026/08/07 UpdatedPrice & Trading Details
2026/08/07 UpdatedPRICE
TRADING
Analyst Recommendations 3 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2013/08/04 | ¥28.00 | ¥34.79 | +24.3% |
| 2011/05/08 | ¥70.64 | ¥5.38 | -92.4% |
| 2006/08/09 | ¥45.91 | ¥34.28 | -25.3% |
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Columbia Fd.s Varbl Series TRT II-Columbia Varbl PORT. - Overseas Core
|
1.1M | -10.20% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
839.8K | -1.50% | |
|
John Hancock Investment Trust-Disciplined Value International Fund
|
651.9K | +0.49% | |
|
American Century ETF Trust-Avantis International Small Cap Value ETF
|
642.1K | +12.87% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
543.2K | +0.52% | |
|
Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund
|
421.8K | +2.78% |
Dividend History
Updated 2026/08/02| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥50 | -50.0% |
| 2025 | ¥100 | +11.1% |
| 2024 | ¥90 | +18.4% |
| 2023 | ¥76 | +5.6% |
| 2022 | ¥72 | - |
Financial Performance
2026/08/02 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥2,239,112M | ¥2,314,828M | ¥2,386,493M | ¥2,399,952M |
| Gross Profit | ¥167,332M | ¥179,694M | ¥185,249M | ¥192,231M |
| Operating Income | ¥20,116M | ¥32,605M | ¥34,876M | ¥37,125M |
| Pretax Income | ¥22,535M | ¥30,636M | ¥42,836M | ¥50,328M |
| Net Income | ¥14,393M | ¥20,345M | ¥29,016M | ¥34,496M |
| EPS | ¥163.19 | ¥236.47 | ¥357.88 | ¥454.58 |
| Operating Margin | 0.90% | 1.41% | 1.46% | 1.55% |
| Balance Sheet | ||||
| Total Assets | ¥1,141,717M | ¥1,146,097M | ¥1,228,686M | ¥1,113,831M |
| Total Equity | ¥417,686M | ¥411,208M | ¥416,306M | ¥407,291M |
| Total Liabilities | ¥724,031M | ¥734,889M | ¥812,380M | ¥706,540M |
| Cash | ¥141,377M | ¥109,026M | ¥181,830M | ¥102,655M |
| Interest-bearing Debt | - | - | - | - |
| Equity Ratio | 36.58% | 35.88% | 33.88% | 36.57% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow | ||||
| Operating CF | ¥9,520M | ¥37,270M | ¥87,216M | -¥65,079M |
| Investing CF | ¥1,439M | -¥46,361M | ¥10,350M | ¥20,378M |
| Financing CF | -¥11,599M | -¥26,219M | -¥31,716M | -¥35,483M |
| Free CF | -¥4,772M | ¥19,528M | ¥71,576M | -¥83,726M |
| Efficiency | ||||
| ROE | 3.45% | 4.95% | 6.97% | 8.47% |
| ROA | 1.26% | 1.78% | 2.36% | 3.10% |
Latest IR Information
-
【Zuken】Earthquake Impact and Future Response｜July 2026
Due to the Kumamoto earthquake that occurred on July 28, 2026, all employees have been confirmed safe, and some damage was confirmed at the Kumamoto factory. The impact on performance is under investigation, and further announcements are awaited.
Read more -
Resolution to Conduct Share Buyback｜July 24, 2026
Zuken plans to dispose of 36,366 shares of treasury stock at 4,977 yen per share on July 24, 2026, raising approximately 108.09 million yen. This action is part of a stock compensation scheme aimed at incentivizing executives and enhancing corporate...
Read more -
【Zuken】Improving Liquidity through Share Split ｜ September 2026
Zuken will implement a share split on September 30, 2026, to reduce investment units and enhance liquidity. Following the split, the number of issued shares will increase by 72,167,204 shares, reaching a total of 144,334,408 shares. Dividend forecasts have also...
Read more -
[Suzuken] Revised Medium-Term Management Plan and Management with Capital Cost Awareness｜May 2026
Suzuken has formulated a medium-term management plan for fiscal years 2027-2029, aiming to achieve an ROE of 8%. The company will focus on evolving into the next-generation distributor, redesigning its business portfolio, and strengthening its management foundation, while also implementing...
Read more -
【Suzuken】2026 Financial Results｜Sales of ¥2.4866 Trillion, 10.6% Increase in Net Income
Suzuken achieved net sales of ¥2.4866 trillion (up 3.6% YoY) and net income attributable to owners of the parent of ¥38.136 billion (up 10.6%) for the fiscal year ending March 2026. Based on mid-term management plans, the company is promoting...
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥6,133
Rating Score: 2.33 (Based on 3 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, and Healthcare Related Services. The Pharmaceutical Distribution Business segment purchases ethical drugs, diagnostic agents, medical equipment, medical materials, and medical food products, as well as pharmaceutical and medical equipment manufacturers, and supplies medical institutions, and insurance pharmacies. The Healthcare Product Development segment offers ethical drugs, diagnostic reagents, and medical devices and materials. The Community Healthcare and Nursing Care Support segment provides a range of pharmacy and nursing care services. The Healthcare Related Services segment offers contract distribution for manufacturers and contract distribution of orphan drugs. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
